Doxoma-L 20 mg Injection 10 ml Substitute
RXBDR Pharmaceuticals Internationals Pvt Ltd
₹3045.5
(₹249.73/ 1ml)
RXGetwell Life Sciences India Pvt Ltd
₹10661
(₹375.27/ 1ml)
RXBiomak Laboratories Pvt Ltd
₹9460
(₹378.4/ 1ml)
RXAxiommax Oncology Pvt Ltd
₹5130
(₹513.0/ 1ml)
RXMetta Life Sciences Pvt Ltd
₹4070
(₹4070.0 per unit)
Patients may explore substitutes in the following scenarios:
Before you switch from Doxoma-L 20 mg Injection 10 ml to another medicine, here are some important points to keep in mind:
Same salt, different brands:
Most substitutes contain the same active ingredient - DOXORUBICIN-2MG, but the fillers, coating, or manufacturing quality may vary slightly.
Consult your doctor first:
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Watch out for allergies or reactions:
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
Price ≠ effectiveness:
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Check the dosage form and strength:
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Doxoma-L 20 mg Injection 10 ml is used to treat various types of cancer. The detailed uses of Doxoma-L 20 mg Injection 10 ml are as follows:
Doxoma-L 20 mg Injection 10 ml contains Doxorubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, thereby destroying the DNA and RNA synthesis. Doxoma-L 20 mg Injection 10 ml is also used in the treatment of acute lymphoblastic leukaemia, acute myeloblastic leukaemia, Hodgkin lymphoma, Non-Hodgkin lymphoma, metastatic breast cancer, metastatic Wilms’ tumour, metastatic neuroblastoma, metastatic soft tissue sarcoma, metastatic bone sarcomas, metastatic ovarian carcinoma, metastatic transitional cell bladder carcinoma, metastatic thyroid carcinoma, metastatic gastric carcinoma, metastatic bronchogenic carcinoma.
The substitutes of Doxoma-L 20 mg Injection 10 ml contain the same active salt(s) - DOXORUBICIN-2MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Doxoma-L 20 mg Injection 10 ml is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Doxoma-L 20 mg Injection 10 ml are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Doxoma-L 20 mg Injection 10 ml meet the same safety and efficacy standards as Doxoma-L 20 mg Injection 10 ml, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Doxoma-L 20 mg Injection 10 ml may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Doxoma-L 20 mg Injection 10 ml if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Doxoma-L 20 mg Injection 10 ml for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Doxoma-L 20 mg Injection 10 ml is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Doxoma-L 20 mg Injection 10 ml to its substitute. Always consult your doctor before switching.
Doxoma-L 20 mg Injection 10 ml is used to treat Breast Cancer.
Doxoma-L 20 mg Injection 10 ml contains Doxorubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, thereby destroying the DNA and RNA synthesis.
Doxoma-L 20 mg Injection 10 ml can disrupt a woman's natural menstrual cycle (period) and inhibit sperm production in men. However, you should not presume that you cannot become pregnant or that you cannot make someone else pregnant. It may also harm your foetus. Use reliable methods of birth control while on treatment with Doxoma-L 20 mg Injection 10 ml.
Yes, Doxoma-L 20 mg Injection 10 ml is considered a vesicant. This means it may cause tissue blistering and damage if it leaks out of the vein during administration in some individuals. Hence, this medication must be administered by a trained healthcare professional to reduce the risk of this complication.
The common side effects of Doxoma-L 20 mg Injection 10 ml may include nausea, headache, abdominal pain, loss of appetite, vomiting, dizziness, mouth sores, tiredness, back pain, red discoloration of urine, diarrhoea, and pain at the injection site. Most of these side effects are mild and temporary, and they often resolve on their own over time. However, if you experience persistent, severe, or worsening side effects, it's crucial to consult your doctor.
It is not recommended for use in breastfeeding women as it may pass into breast milk and harm your infant. Hence, if you are breastfeeding, inform your doctor before prescribing Doxoma-L 20 mg Injection 10 ml.
Doxoma-L 20 mg Injection 10 ml is an anti-cancer medication used to treat various types of cancer. It belongs to the class of anthracycline topoisomerase inhibitors.
Alcohol intake might increase the risk of stomach or intestine bleeding. Alcohol consumption is not recommended during the treatment.